We flew to the UK to learn more about the designer 3D-printing third thumbs. Is this the dawn of human body augmentation?
Watch the Hard Reset series ► https://www.youtube.com/playlist?list=PLXthoedLVIdLvnNgiCshQvqKdS7T_qeGY
Continue reading “Bionic 3rd thumb: The future of human augmentation | Hard Reset” »
The Memo: https://lifearchitect.ai/memo/
Read the paper: https://arxiv.org/abs/2212.08073
GitHub repo: https://github.com/anthropics/ConstitutionalHarmlessnessPaper/tree/main/samples.
❤️ Check out Lambda here and sign up for their GPU Cloud: https://lambdalabs.com/papers.
📝 The paper “Improving Multimodal Interactive Agents with Reinforcement Learning from Human Feedback” is available here:
https://www.deepmind.com/blog/building-interactive-agents-in-video-game-worlds.
Continue reading “DeepMind’s New AI Surpasses Humans At Some Things!” »
Scientists at the University of Cambridge have successfully trialed an artificial pancreas for use by patients living with type 2 diabetes. The device – powered by an algorithm developed at the University of Cambridge – doubled the amount of time patients were in the target range for glucose compared to standard treatment and halved the time spent experiencing high glucose levels.
Around 415 million people worldwide are estimated to be living with type 2 diabetes, which costs around $760 billion in annual global health expenditure. According to Diabetes UK, more than 4.9 million people have diabetes in the UK alone, of whom 90% have type 2 diabetes, and this is estimated to cost the NHS £10 billion per year.
“Many people with type 2 diabetes struggle to manage their blood sugar levels using the currently available treatments, such as insulin injections. The artificial pancreas can provide a safe and effective approach to help them, and the technology is simple to use and can be implemented safely at home.” —
San Diego-based biotech startup Rejuvenate Bio is making a major claim that’ll likely draw heated scrutiny from the scientific community: that its technology was able to significantly extend the lives of elderly mice.
According to a yet-to-be-peer-reviewed paper, scientists at the company say an injection that reprograms genes in the bodies of senior mice effectively doubled their remaining life span, MIT Technology Review reports.
In tests, the company found that treated mice lived on for another 18 weeks on average. Those who were not treated in a control group only lived for another nine weeks. Overall, they say, the gene hacked mice lived roughly seven percent longer overall.
Scientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have discovered that a protein, called Menin, contributes to abnormal deactivation of specific genes in cancer cells.
One of the hallmarks of cancer is that the normal regulation of genes is disrupted, and this causes cancer cells to look and behave differently to normal cells. Cancer cells can switch off certain genes, keeping them in a dormant state. By deactivating specific immune genes, some cancers are able to evade detection by the immune system, essentially becoming invisible. This allows the cancer to grow and become more aggressive.
By targeting the Menin protein using drug therapies, the researchers believe they can reactivate these genes, making the cancer cells once again visible and allowing the immune system to seek out and destroy them.
DeepMind brought artificial intelligence mainstream. Now its CEO Demis Hassabis is issuing a warning.
Tesla is the cheapest luxury brand to maintain, and not just among electric vehicle brands, but also those with internal combustion engines (ICE), according to a new study.
The findings come from Clunker Junker which looked at maintenance cost data from the last ten years and cross-referenced vehicle price data.
As in most auto studies, they divided brands and vehicles into popular and luxury. The popular car winner was Toyota. The Japanese automaker took eight of the top ten cheapest cars to maintain.
